Tag: John Kamp

CHC_FDA-Regulatory Images1

06/14/2018

FDA Final Guidance Documents on Communication Issues Improve Clarity

CHC_Legislative1

06/13/2018

Azar Says FDA Has Authority to Require List Prices in Drug Ads

CHC_DTCadvertisement2

05/21/2018

Debate over Listing Drug Prices in Ads Continues

kamp-john

05/16/2018

Kamp Commentary: Disclosure of Drug Prices in Ads Not a Done Deal

CHC_washingtonfocus2

05/14/2018

White House Plan to Lower Drug Prices Takes Incremental Approach

04/09/2018

What Happens in Washington Doesn’t Stay in Washington

CHC_general2

03/26/2018

FDA Announces Mobile App to Help Consumers Get Drug Info

CHC_DTCadvertisement1

03/14/2018

FDA Ramps Up Drug Promotion Research Focus

CHC_Legislative2

02/05/2018

Oregon Transparency Bill Calls for Reporting of Marketing Costs